Quinoxalinone derivative with matrix metalloproteinase inhibitory activity and preparation method and application thereof
Patent Information
- Authority / Receiving Office
- CN ยท China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SHANDONG UNIV
- Publication Date
- 2010-05-12
- Estimated Expiration
- Not applicable ยท inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to quinoxalinone derivatives capable of inhibiting matrix metalloproteinases, a preparation method and application thereof, and belongs to the technical field of medicinal chemistry. Background technique
[0002] Malignant tumors are one of the main diseases causing human death, and it is imminent to find highly selective anticancer drugs with high efficiency and low toxicity. Matrix metalloproteinases (Matrix metalloproteinases, MMPs) are a class of endopeptidases whose activity depends on zinc ions. Their main physiological function is to degrade and rebuild the extracellular matrix. Plays a key role in blood vessel growth. At present, 28 mammalian MMP subtypes have been discovered, so many MMPs family members are classified, and because the high expression of MMPs participates in many physiological processes of the human body, it is obviously inappropriate to inhibit all MMPs family members. People thus realize the importance...